Workflow
Brain Computer Interface (BCI)
icon
Search documents
How To Build The Future: Max Hodak
Y Combinator· 2026-03-09 14:00
I think it is very possible that the first people to live to a thousand are alive right now. It still takes some suspension of disbelief because I think biotech has just been so incremental. One of the things that's so exciting about what's happening now is that no longer really feels so incremental to me.I think that BCI we're going to come to see is not is not a specific product. I think there going to be a bunch of BCI companies going after different applications where different types of probes will make ...
Synchron vs. Neuralink: BCI Brain Implants for Thought-Control
CNET· 2025-08-10 12:00
BCI Technology Overview - Synchron and Neuralink are leading companies in the Brain Computer Interface (BCI) field, developing brain implants to enable users to control digital devices with their thoughts [1][2][3] - Both companies aim to assist individuals with paralysis by enabling them to control digital devices using their thoughts [12] Device and Technology - Synchron's Stentrode uses a minimally invasive approach, implanting a stent-based device into a blood vessel near the brain's motor cortex with 16 electrodes or channels [3][4][7] - Neuralink's Telepathy involves a more invasive process, directly inserting threads into the brain using a surgical robot, featuring 1,000 electrodes or channels [7][9] - Neuralink aims to triple the number of electrodes next year and implant their first patient with blind sight [7] Implant Process and Risks - Synchron's Stentrode implantation carries the risk of blood clots, managed with medication, with the risk decreasing over time [8] - Neuralink's implantation risks include thread retraction or movement, potentially reducing usable channels [10] Development Stage and Vision - Synchron expects the Stentrode to cost between $50,000 and $100,000, comparable to other implantable medical devices [11] - Neuralink is currently in clinical trials and has received approval to launch trials in Canada, the UK, and the United Arab Emirates [11] - Neuralink envisions expanding access to implants beyond medical needs, aiming for bidirectional communication with the brain and increased bandwidth [12]